Lipemic serum in patients with Coronavirus Disease 2019 (COVID-19) undergoing treatment

J Med Virol. 2020 Oct;92(10):1810-1811. doi: 10.1002/jmv.25942. Epub 2020 Jun 2.

Authors

Abdur Rahman Rubel¹, Pui Lin Chong², Muhammad Syafiq Abdullah^{2

3}, Rosmonaliza Asli⁴, Riamiza Natalie Momin⁴, Babu Ivan Mani¹, Vui Heng Chong^{1

2

3}

Affiliations

¹ Department of Internal Medicine, PMMPMHAMB Hospital, Tutong, Brunei Darussalam.
² Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam.
³ Institute of Health Science, PAPRSB, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam.
⁴ Infectious Disease Unit, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
COVID-19*
Humans
Hypertriglyceridemia*
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
tocilizumab